Fendos and Engelman: pHLIP and acidity as universal biomarker for cancer 35 possibility of false-positives for cancer de- tection, particularly in older patients with chronic inflammatory disorders. Neverthe- less, pHLIP shows great promise as a diag- nostic tool, and we hope continuing work will yield new interest and ideas in the use of pH as a universal biomarker for cancer. Acknowledgments: We thank NIH and Do D for their support, as well as our collaborators Yana r eshetnyak and o leg Andreev for their essential contributions to this work. r e Fe r e n Ce S 1. Simon E. Biological and chemical sensors for cancer diagnosis. Meas Sci Technol. 2010;21(11):112002. 2. Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L. Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Meth- ods in a Molecularly Characterized Cohort of Breast Cancer Specimens. J Clin Oncol. 2002;20(14):3095-105. 3. Schwarzenbach H, Hoon DS, Pantel K. Cell- free Nucleic Acids as Biomarkers in Cancer Patients. Nat Rev Cancer. 2011;11(6):426-37. 4. Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA. pH imaging. A review of pH measurement methods and applications in can- cers. IEEE Eng Med Biol Mag. 2004;23(5):57- 64. 5. Warburg O. On the Origin of Cancer Cells. Science. 1956.;123(3191):309-14. 6. Wike-Hooley JL, Haveman J, Reinhold HS. The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol. 1984;2(4):343-66. 7. Gatenby RA, Gawlinski ET, Gmitro AF, Kay- lor B, Gillies RJ. Acid-mediated tumor inva- sion: a multidisciplinary study. Cancer Res. 2006;66(10):5216-23. 8. Rofstad EK, Mathiesen B, Kindem K, Galap- pathi K. Acidic extracellular pH promotes ex- perimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 2006;66(13):6699-707. 9. Stubbs M, McSheehy PM, Griffiths JR. Causes and consequences of acidic pH in tu- mors: a magnetic resonance study. Adv En- zyme Regul. 1999;39:13-30. 10. Kallinowski F, Vaupel P. pH distributions in spontaneous and isotransplanted rat tumours. Br J Cancer. 1988;58(3):314-21. 11. Hunt JF, Rath P, Rothschild KJ, Engelman DM. Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix. Bio- chemistry. 1997;36(49):15177-92. 12. Popot JL, Engelman DM. Membrane protein folding and oligomerization: the two-stage model. Biochemistry. 1990;29(17):4031-7. 13. Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proc Natl Acad Sci USA. 2008;105(40):15340-5. 14. Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proc Natl Acad Sci USA. 2006;103(17):6460-5. 15. Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci USA. 2007;104(19):7893-8. 16. Izumi H. Cellular pH regulators: poten- tially promising molecular targets for cancer chemotherapy. Cancer Treat Rev. 2003;29(6):541-9. 17. Reshetnyak YK, Segala M, Andreev OA, En- gelman DM. A monomeric membrane pep- tide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophys J. 2007;93(7):2363-72. 18. Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK. pH (low) insertion peptide (pHLIP) in- serts across a lipid bilayer as a helix and exits by a different path. Proc Natl Acad Sci USA. 2010;107(9):4081-6. 19. An M, Wijesinghe D, Andreev OA, Reshet- nyak YK, Engelman DM. pH-(low)-inser- tion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin in- hibits cancer cell proliferation. Proc Natl Acad Sci USA. 2010;107(47):20246-50. 20. Vavere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, et al. A novel technology for the imaging of acidic prostate tumors by positron emission tomog- raphy. Cancer Res. 2009;69(10):4510-6. 21. Segala J, Engelman DM, Reshetnyak YK, Andreev OA. Accurate analysis of tumor margins using a fluorescent pH low insertion peptide. Int J Mol Sci. 2009;10(8):3478-87.